BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2066753)

  • 1. Phase II trial of pentostatin in refractory lymphomas and cutaneous T-cell disease.
    Cummings FJ; Kim K; Neiman RS; Comis RL; Oken MM; Weitzman SA; Mann RB; O'Connell MJ
    J Clin Oncol; 1991 Apr; 9(4):565-71. PubMed ID: 2066753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentostatin (2'-deoxycoformycin, dCF) in patients with low-grade (B-T-cell) and intermediate- and high-grade (T-cell) malignant lymphomas: phase II study of the EORTC Early Clinical Trials Group.
    Monfardini S; Sorio R; Cavalli F; Cerny TH; Van Glabbeke M; Kaye S; Smyth JF
    Oncology; 1996; 53(2):163-8. PubMed ID: 8604244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2' Deoxycoformycin (pentostatin) for refractory non-Hodgkin's lymphoma: a CALGB phase II study.
    Duggan DB; Anderson JR; Dillman R; Case D; Gottlieb AJ
    Med Pediatr Oncol; 1990; 18(3):203-6. PubMed ID: 2329964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of pentostatin (Nipent) in cutaneous T-cell lymphoma: single-agent and combination studies.
    Foss FM
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):58-63. PubMed ID: 10877054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
    Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentostatin (2'-deoxycoformycin) in the treatment of cutaneous T-cell lymphoma.
    Greiner D; Olsen EA; Petroni G
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):950-5. PubMed ID: 9204061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma.
    O'Connell MJ; Harrington DP; Earle JD; Johnson GJ; Glick JH; Carbone PP; Creech RH; Neiman RS; Mann RB; Silverstein MN
    J Clin Oncol; 1987 Sep; 5(9):1329-39. PubMed ID: 2442322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentostatin (Nipent) in T-cell lymphomas.
    Kurzrock R
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):64-6. PubMed ID: 10877055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype.
    Mercieca J; Matutes E; Dearden C; MacLennan K; Catovsky D
    J Clin Oncol; 1994 Dec; 12(12):2588-93. PubMed ID: 7989933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of YK-176 (2'-deoxycoformycin) in patients with adult T-cell leukemia-lymphoma. The DCF Study Group.
    Tobinai K; Shimoyama M; Inoue S; Takayasu S; Mikuni C; Kozuru M; Oda S; Nakajima H
    Jpn J Clin Oncol; 1992 Jun; 22(3):164-71. PubMed ID: 1518164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentostatin treatment of cutaneous T-cell lymphoma.
    Dearden C; Matutes E; Catovsky D
    Oncology (Williston Park); 2000 Jun; 14(6 Suppl 2):37-40. PubMed ID: 10887643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
    Willis CR; Goodrich A; Park K; Waselenko JK; Lucas M; Reese A; Diehl LF; Grever MR; Byrd JC; Flinn IW
    Ann Hematol; 2006 May; 85(5):301-7. PubMed ID: 16518606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a phase II multicenter trial of pentostatin and rituximab in patients with low grade B-cell non-Hodgkin's lymphoma: an effective and minimally toxic regimen.
    Drapkin R; Di Bella NJ; Faragher DC; Harden E; Matei C; Hyman W; Mirabel M; Boehm KA; Asmar L
    Clin Lymphoma; 2003 Dec; 4(3):169-75. PubMed ID: 14715099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
    Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentostatin in T-non-Hodgkin's lymphomas: efficacy and effect on CD26+ T lymphocytes.
    Dang NH; Hagemeister FB; Duvic M; Romaguera JE; Younes A; Jones D; Samuels B; Fayad LE; Pro B; Samaniego F; Sarris A; Goy A; McLaughlin P; Tong AT; Walker PL; Tiongson LP; Smith TL; Huh YO; Morimoto C; Rodriguez MA
    Oncol Rep; 2003; 10(5):1513-8. PubMed ID: 12883733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentostatin in T-cell malignancies--a phase II trial of the EORTC. Leukemia Cooperative Group.
    Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
    Ann Oncol; 1999 Dec; 10(12):1493-8. PubMed ID: 10643542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II trial of teniposide (VM 26) in advanced non-Hodgkin's lymphoma, with emphasis on the treatment of elderly patients.
    Tirelli U; Carbone A; Crivellari D; Volpe R; Franchin G; Veronesi A; Galligioni E; Trovò M; Tumolo S; Grigoletto E
    Cancer; 1984 Aug; 54(3):393-6. PubMed ID: 6375853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group.
    Döhner H; Ho AD; Thaler J; Stryckmans P; Sonneveld P; de Witte T; Lechner K; Lauria F; Bödewadt-Radzun S; Suciu S
    J Natl Cancer Inst; 1993 Apr; 85(8):658-62. PubMed ID: 8468724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentostatin, chlorambucil and prednisone therapy for B-chronic lymphocytic leukemia: a phase I/II study by the Eastern Cooperative Oncology Group study E1488.
    Oken MM; Lee S; Kay NE; Knospe W; Cassileth PA
    Leuk Lymphoma; 2004 Jan; 45(1):79-84. PubMed ID: 15061201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentostatin therapy of T-cell lymphomas with cutaneous manifestations.
    Kurzrock R; Pilat S; Duvic M
    J Clin Oncol; 1999 Oct; 17(10):3117-21. PubMed ID: 10506607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.